U.S. Electric Utilities Stock News

Recent stock performance snapshot Plug Power (PLUG) has seen sharp price swings recently, with the stock down 8.8% in the past day and 28.9% over the past week, while the past 3 months show a 30.5% gain. Over longer periods, the stock is up 127.3% over the past year but has fallen 73.3% over 3 years and 90.0% over 5 years, highlighting how timing has heavily influenced investor experience. See our latest analysis for Plug Power. At a share price of US$2.91, Plug Power’s recent pullback,...

In recent days, ProFrac Holding was swept up in sharp swings across energy stocks as direct military actions between Israel and Iran, and subsequent US comments on a possible response over the Strait of Hormuz, heightened and then partially eased geopolitical risk concerns for the oil and gas sector. This turmoil underscored how ProFrac’s fortunes can be influenced less by its own operations and more by shifting expectations around global supply security and demand for energy services amid...

In early June 2026, CareDx reported Q1 revenue growth of 39% year over year, raised full-year guidance to US$447–US$465 million with adjusted EBITDA of US$43–US$57 million, advanced its AI-enabled transplant diagnostics, and agreed to acquire Naveris while its CEO Hanna John Walter JR sold 4,835 shares as part of ongoing insider sales. The Naveris deal shifts CareDx further into oncology minimal residual disease testing with Medicare-covered NavDx and a planned AlloHeme launch for AML and...

In recent weeks, Arcus Biosciences announced a clinical trial collaboration with Bristol Myers Squibb to add its HIF-2a inhibitor casdatifan to the BMS-sponsored ROSETTA RCC-208 trial in advanced renal cell carcinoma, while regulators accepted a Priority Review for Camzyos in adolescent obstructive hypertrophic cardiomyopathy and approved Opdivo plus AVD for newly diagnosed advanced classical Hodgkin lymphoma in the EU. Together with positive Phase 3 data for the multiple myeloma candidate...

Zai Lab Limited recently announced that China’s National Medical Products Administration approved the Biologics License Application for TIVDAK (tisotumab vedotin) to treat adult patients with recurrent or metastatic cervical cancer whose disease progressed on or after chemotherapy, based on the Phase 3 innovaTV 301 trial showing an overall survival benefit and no new safety signals in the China subpopulation. This approval gives Zai Lab exclusive rights to commercialize TIVDAK across Greater...

Alnylam Pharmaceuticals (ALNY) has come back into focus after the company outlined 2030 financial goals and reiterated AMVUTTRA’s central role, even as fresh headlines highlighted its AI partnership with Inceptive Nucleics. See our latest analysis for Alnylam Pharmaceuticals. Despite the recent AI collaboration and refreshed 2030 goals, Alnylam’s share price has been under pressure year to date, with a year to date share price return of down 25.6%. However, the 3 year total shareholder return...

Knife River (KNF) moved higher alongside a broad rally in building materials stocks, as investors reacted to more upbeat sentiment around infrastructure spending, housing activity, and construction forecasts across the industry. See our latest analysis for Knife River. That move comes after a mixed stretch, with the stock’s 1 day share price return of 5.72% standing against a 30 day share price return down 15.64% and a 1 year total shareholder return down 14.45%, while the 3 year total...

Emerson Electric (EMR) is back in focus after announcing a collaboration with SiMa.ai to bring machine learning System on Chip technology into its industrial PCs, putting fresh attention on the stock’s Industrial AI ambitions. See our latest analysis for Emerson Electric. Emerson Electric’s recent Industrial AI partnership with SiMa.ai comes after a steady year of gains, with the share price up 4.86% year to date and a 1-year total shareholder return of 14.02%. The 3-year total shareholder...

In early June 2026, Beam Therapeutics reported positive clinical trial data for its gene-editing candidate BEAM-302, showing sustained protective protein levels that support a potential accelerated review pathway by the FDA for treating alpha-1 antitrypsin deficiency. This progress in BEAM-302 strengthens Beam’s broader precision genetic medicine pipeline, underscoring how individual program milestones can influence perceptions of its overall technology platform and future treatment...

AXIA Energia stock snapshot AXIA Energia (AXIA) has drawn attention after recent trading performance, with the stock at $9.83 and mixed short term returns, including a gain of 1.03% over the past day but pressure over the past month. See our latest analysis for AXIA Energia. Recent trading has been choppy, with the share price down 18.02% over the past 30 days and 16.55% over 90 days, yet the 1 year total shareholder return of 76.22% shows how strongly long term holders have been rewarded. If...

Driven Brands Holdings (DRVN) has drawn investor attention after recent share price moves, with the stock down 1.9% on the day and mixed returns over the week, month, and past 3 months. See our latest analysis for Driven Brands Holdings. At a share price of $13.21, recent weakness, including a 1 day share price return decline of 1.93%, comes after a stronger 90 day share price return of 25.33%. However, the 1 year total shareholder return is down 25.87%, pointing to fading longer term...

Recently, Zacks Investment Research upgraded Stock Yards Bancorp (SYBT) to a Rank #2 (Buy), citing an improved earnings outlook and upward-trending estimates. This shift in analyst view, combined with neutral short-term quantitative signals, highlights a changing perception of the bank’s earnings resilience. We’ll now examine how this Zacks Rank upgrade, tied to improved earnings expectations, reshapes Stock Yards Bancorp’s broader investment narrative. Outshine the giants: these 14...

What the Tuscaloosa resort announcement means for Travel + Leisure (TNL) Travel + Leisure (TNL) is extending its Sports Illustrated Resorts brand with a ground-up, mixed-use project in Tuscaloosa, Alabama, near the University of Alabama, tying year-round hospitality and residential offerings to a large college sports market. See our latest analysis for Travel + Leisure. Recent momentum has been building, with a 1-month share price return of 9.71% and a 1-year total shareholder return of...

Why Sotera Health is back in focus Goldman Sachs has initiated coverage of Sotera Health (SHC), just as the company reports first quarter 2026 earnings that topped revenue and profit expectations and gains clarity on Ethylene Oxide related legal exposures. See our latest analysis for Sotera Health. The recent 1 day share price return of 4.22% to US$16.53, alongside a 90 day share price return of 18.75% and 1 year total shareholder return of 34.39%, points to momentum building as investors...

In recent months Novavax reported a narrower-than-expected quarterly loss with revenue beating forecasts, while shifting its COVID-19 commercialization in Europe to Sanofi and emphasizing licensing of its Matrix-M adjuvant. Despite these partnership-driven revenues and management’s confidence in funding operations into 2028, investors remain focused on concerns about long-term growth, declining vaccination demand, and balance-sheet resilience. Now we’ll examine how Novavax’s pivot toward...

In recent days, Quest Diagnostics has attracted favorable attention from Wall Street, with analysts issuing 9 buy and 9 hold ratings and no sell calls, reflecting confidence in its broad portfolio of diagnostic testing and healthcare services across the United States. This cluster of positive opinions highlights how Quest’s diversified offering and perceived financial resilience are shaping analyst views on its role in an evolving healthcare landscape. We’ll now examine how this upbeat...

Why Vulcan Materials stock is back in focus Vulcan Materials (VMC) is back on investor radar after it sold its ready mixed concrete operations in California and bought select Brannan Sand & Gravel assets in southern Colorado and Dallas Fort Worth. The deal adds a rail connected aggregate quarry with long term reserves in Lamar, Colorado, plus a new Dallas Fort Worth distribution yard, giving investors fresh information on how Vulcan is concentrating on aggregates-led growth and reshaping its...

Fox Corporation and the National Football League previously announced a multi-year agreement to bring an extensive slate of live NFL games and original football programming to Fox’s linear, streaming and ad-supported platforms in Mexico starting with the 2026 season. This expansion into Mexico deepens Fox’s relationship with premium live sports while broadening its reach across Latin American audiences and digital services like FOX One and Tubi. Next, we’ll examine how adding comprehensive...

Smelter expansion and auditor change put United States Antimony (UAMY) in focus United States Antimony (UAMY) is drawing fresh attention after commissioning its new Thompson Falls antimony smelter, with the first of nine gas fired furnaces online and renovation of the older facility deferred to 2027. See our latest analysis for United States Antimony. That smelter commissioning and the routine auditor change are landing against a sharp pullback, with the share price down 31.7% over 30 days...

Event context for ERock (EROC) ERock (EROC) is on investor radars after fresh attention on its modular power systems business for data centers, utilities, and commercial clients. The stock last closed at US$21.50 and has a market cap around US$4.71b. See our latest analysis for ERock. With year to date share price returns at 0.00%, the recent focus on ERock’s modular power systems is putting more weight on future execution and risk expectations than on past trading momentum. If this kind of...

Aeropay’s decision to use Jack Henry & Associates (JKHY) embedded payments technology puts the company’s Payments Orchestrator at the center of real time, pay by bank transaction routing and resilience. See our latest analysis for Jack Henry & Associates. Despite Aeropay’s integration highlighting Jack Henry’s role in real time payments, recent share price performance has been weak. The stock is down about 12.7% over 30 days and around 23.8% over 90 days, while the 1 year total shareholder...

A federal judge has denied motions to dismiss a class-action lawsuit alleging that Portland General Electric and other operators helped contaminate groundwater in Oregon’s Lower Umatilla Basin, allowing claims under federal and state law to proceed toward a jury trial scheduled for May 2027. The case not only raises potential liability over alleged nitrate-related health impacts for tens of thousands of residents, but also spotlights how Portland General Electric’s industrial wastewater...

Quarterly earnings and long-term outlook draw attention NiSource (NI) recently reported first quarter 2025 operating EPS of $1.06, in line with consensus, with revenue of $2.37b, and raised its long term non GAAP earnings growth outlook through 2033. See our latest analysis for NiSource. At a share price of US$46.33, NiSource has posted a 9.9% year to date share price gain, alongside a 20.2% total shareholder return over the past year. This suggests momentum has been building as investors...

Waystar Holding (WAY) has drawn fresh attention after publishing The State of the Mid-Revenue Cycle report, which spotlights healthcare finance leaders’ push for a single AI-powered platform that links mid-cycle workflows with final claims processing. See our latest analysis for Waystar Holding. Despite the spotlight from its new mid-revenue cycle report, Waystar Holding’s short term momentum has been weak. The share price is down 10.34% over 30 days and 38.89% year to date, while the 1 year...